Colistin Combined With Tigecycline: A Promising Alternative Strategy to Combat Escherichia coli Harboring blaNDM–5 and mcr-1
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Colistin Combined With Tigecycline: A Promising Alternative Strategy to Combat Escherichia coli Harboring blaNDM–5 and mcr-1
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-08
DOI
10.3389/fmicb.2019.02957
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of a potential MCR-1 inhibitor that reverses polymyxin activity against clinical mcr-1-positive Enterobacteriaceae
- (2019) Yonglin Zhou et al. JOURNAL OF INFECTION
- Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli
- (2019) Jian Sun et al. Nature Microbiology
- Pterostilbene restores carbapenem susceptibility in NDM‐producing isolates via inhibiting the activity of NDM enzymes
- (2019) Shui Liu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacokinetics of colistin methanesulfonate (CMS) in healthy Chinese subjects after single and multiple intravenous doses
- (2018) Miao Zhao et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Evidence to improve the treatment of infections caused by carbapenem-resistant Gram-negative bacteria
- (2018) Federico Perez et al. LANCET INFECTIOUS DISEASES
- Towards Understanding MCR-like Colistin Resistance
- (2018) Jian Sun et al. TRENDS IN MICROBIOLOGY
- Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics
- (2018) Craig R. MacNair et al. Nature Communications
- Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model
- (2017) Xuejiu Cai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1
- (2017) Yu-Feng Zhou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance
- (2017) Yee-Huang Ku et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Efflux Pump Overexpression Contributes to Tigecycline Heteroresistance in Salmonella enterica serovar Typhimurium
- (2017) Yi Chen et al. Frontiers in Cellular and Infection Microbiology
- Complete Nucleotide Sequence of an IncI2 Plasmid CoharboringblaCTX-M-55andmcr-1
- (2016) Jian Sun et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo
- (2016) Devyani Deshpande et al. CLINICAL INFECTIOUS DISEASES
- Dosing guidance for intravenous colistin in critically-ill patients
- (2016) Roger L Nation et al. CLINICAL INFECTIOUS DISEASES
- Synergy and antagonism between iron chelators and antifungal drugs in Cryptococcus
- (2016) Yu-Wen Lai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model
- (2016) Xiaofen Liu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
- (2016) Thien B. Tran et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii
- (2016) Gauri G. Rao et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Evaluation of antibacterial activities of colistin, rifampicin and meropenem combinations against NDM-1-producingKlebsiella pneumoniaein 24 hin vitrotime–kill experiments
- (2016) P. Lagerbäck et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae
- (2016) Hong Du et al. LANCET INFECTIOUS DISEASES
- Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1
- (2016) Xu Yao et al. LANCET INFECTIOUS DISEASES
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
- (2016) Yi-Yun Liu et al. LANCET INFECTIOUS DISEASES
- Co-transfer of blaNDM-5 and mcr-1 by an IncX3–X4 hybrid plasmid in Escherichia coli
- (2016) Jian Sun et al. Nature Microbiology
- New pharmacokinetic/pharmacodynamic studies of systemically administered colistin againstPseudomonas aeruginosaandAcinetobacter baumanniiin mouse thigh and lung infection models: smaller response in lung infection
- (2015) Soon-Ee Cheah et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-Line Antibiotics against Multidrug-Resistant Gram-Negative Bacteria
- (2015) Kade D. Roberts et al. ACS Infectious Diseases
- Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence
- (2013) Matthew E. Falagas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection
- (2013) Niteen D. Karnik et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii
- (2013) Ilkay Karaoglan et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Bactericidal Activity of Multiple Combinations of Tigecycline and Colistin against NDM-1-Producing Enterobacteriaceae
- (2012) Mahableshwar Albur et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Increased Susceptibility of Pseudomonas aeruginosa to Macrolides and Ketolides in Eukaryotic Cell Culture Media and Biological Fluids Due to Decreased Expression of oprM and Increased Outer-Membrane Permeability
- (2012) Julien M. Buyck et al. CLINICAL INFECTIOUS DISEASES
- Colistin: an update on the antibiotic of the 21st century
- (2012) Silpak Biswas et al. Expert Review of Anti-Infective Therapy
- A Novel Variant, NDM-5, of the New Delhi Metallo-β-Lactamase in a Multidrug-Resistant Escherichia coli ST648 Isolate Recovered from a Patient in the United Kingdom
- (2011) Michael Hornsey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients
- (2011) Wang Liang et al. BMC INFECTIOUS DISEASES
- Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time–kill assay
- (2011) Spyros Pournaras et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli
- (2011) Fernando Docobo-Pérez et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacy and safety of tigecycline: a systematic review and meta-analysis
- (2011) Dafna Yahav et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae
- (2011) B. Bercot et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
- (2009) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
- (2008) Irith Wiegand et al. Nature Protocols
- Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 β-lactamase–producing Klebsiella pneumoniae epidemic clone
- (2007) Javier Cobo et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now